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ABSTRACT
Objectives: We conducted a literature review to respond to
regulatory concerns about the quality of translated patient-
reported outcome questionnaires. Our main objective was to
answer two questions: What do the methods have in common
(and how do they differ)? Is there evidence of the superiority
of one method over another?
Methods: We identiﬁed 891 references by searching
MEDLINE, Embase, and the Mapi Research Trust’s database
with “quality-of-life,” “questionnaires,” “health status indi-
cators” matched with “translating,” “translation issues,”
“cross-cultural research,” and “cross-cultural comparison.”
Articles were included if they proposed, compared or criti-
cized translation methods.
Results: Forty-ﬁve articles met our inclusion criteria: 23 rep-
resenting 17 sets of methods, and 22 reviews. Most articles
recommend a multistep approach involving a centralized
review process. Nevertheless, each group proposes its
own sequence of translation events and weights each step
differently. There is evidence demonstrating that a rigorous
and a multistep procedure leads to better translations. Nev-
ertheless, there is no empirical evidence in favor of one spe-
ciﬁc method.
Conclusions: We need more empirical research on transla-
tion methodologies. Several points emerge from this review.
First, producing high-quality translations is labor-intensive.
Second, the availability of standardized guidelines and cen-
tralized review procedures improves the efﬁciency of the pro-
duction of translations. Although we did not ﬁnd evidence in
favor of one method, we strongly advise researchers to adopt
a multistep approach. In line with the recent Food and Drug
Administration recommendations, we developed a checklist
summarizing the steps used for translations, which can be
used to evaluate the rigor of the applied methodologies.
Keywords: clinical trials, cross-cultural research, health-
related quality of life, patient-reported outcomes, PRO ques-
tionnaires, review, translation issues.
Introduction
The increased prevalence of chronic illnesses [1,2],
the call for greater patient empowerment [3], and
advances in information technology [4–7] have con-
tributed to a rising interest in patients’ views about
outcomes of treatment. Changes in a patient’s self-
assessment of the impact of treatment can only be
measured by asking the patient. Patrick [8] points out
that some outcomes are known only to the patient,
such as the evaluation of how satisﬁed one is with
one’s life, and these cannot be veriﬁed by other evi-
dence. Other outcomes, such as reports of physical
function, can be observed by others.
The extent to which these patient-reported out-
comes can be used to evaluate and communicate the
effect of new drugs and devices is still a subject of
much debate. Although there remains concern about
the value and application of patients’ self-assessment
in the evaluation of new therapies, regulators are
showing interest in these outcomes. Both the European
Agency for the Evaluation of Medicinal Products
(EMEA) [9] and the United States Food and Drug
Administration (FDA) [10] have recently issued guid-
ance for the use of patients’ self-assessed outcomes in
the evaluation of medicinal products.
When pharmaceutical companies evaluate new
medicines in clinical trials in different countries, as is
the case with regulatory agencies, they need assurance
that patients’ self-assessment of their condition and the
effects of treatment are valid across the different coun-
tries, irrespective of the patients’ language and cultural
background. Many questionnaires, mainly developed
in English for Anglo-Saxon cultures, have been trans-
lated for use in other countries and/or cultures, and
European regulators are rightfully concerned about
their validity in measuring the same concepts. The
EMEA clearly voiced these concerns as one of their
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key issues: “Are HRQL instruments internationally
validated?” [11] The FDA shares the same concerns in
its recent draft guidance on the use of Patient-Reported
Outcome (PRO) measures in the evaluation of medici-
nal products, section IV.D.5. Changed Culture or
Language of Application, and provides some recom-
mendations [10]. The guidance states that: “The FDA
recommends that sponsors provide evidence that the
methods and results of the translation process were
adequate to ensure that the validity of the responses is
not affected. [. . .] Sponsors should consider whether
generally accepted standards for translation and cul-
tural adaptation have been used to support the validity
of data from a translated/adapted PRO instrument. As
reported by Bullinger and colleagues [12], “Culture
and nations differ with regard to a more ethnological
or political perspective.” Cultural diversity may exist
in one nation (e.g., USA) although other nations may
be relatively culturally close because of similar origins
(e.g., Scandinavian countries). Acquadro and col-
leagues [13] also state that communication between
cultures depends on equivalence in thoughts and situ-
ations and not just equivalence in expressions. Never-
theless, similarity in thoughts and situations between
cultures may not exist. Sartorius and Kuyken [14]
highlighted this issue when they pointed out differ-
ences that exist between cultures in their concepts of
health and illness, levels of literacy, reading level, con-
cordance between written and spoken versions of lan-
guage, taboo subjects, and social desirability effects.
Thus, equivalence of international versions of Health-
Related Quality of Life (HRQL) instruments is key
to their use in cross-cultural research. How this
equivalence can be reached is still under discussion,
and several taxonomies of equivalence have been
developed [14–19].
Stewart and Napoles-Springer [19] provide a tax-
onomy for assessing equivalence that integrates and
modiﬁes the approaches of numerous researchers.
They describe six levels of equivalence and the basic
methods for addressing each type of equivalence. Con-
ceptual equivalence of constructs and items is achieved
when the constructs exist, are relevant and are accept-
able in all cultures. The items should also represent the
deﬁnition of the constructs. Semantic equivalence is
obtained when items mean the same thing to people
from different groups and in the target and source
language. Operational equivalence ensures that
standardized methods of survey administration are
appropriate for the target culture. Psychometric or
measurement equivalence is achieved when compa-
rable psychometric properties are observed in the
source and target measures. Item equivalence is
observed when 1) items are not differentially more
difﬁcult (e.g., biased) in the target culture than in the
original; 2) item weights reﬂect comparative impor-
tance of items in all groups; and 3) the meaning of and
distance between response choices is similar across
cultures. Finally, criterion equivalence is obtained
when the interpretation of scores is the same across
groups, and when compared with norms for each
group. Translated versions should also demonstrate
similar associations with any previously set indepen-
dent criterion established during the validation of the
original version.
Objectives
In response to regulators’ concerns, Mapi Research
Institute and the European Regulatory Issues on
Quality of Life Assessment (ERIQA) group investi-
gated current methods and guidelines for translating
HRQL questionnaires. A literature review was con-
ducted of methods used to achieve conceptual, seman-
tic and operational equivalence [19] (often referred to
as linguistic validation). The review was intended to
answer the following questions: 1) what do the various
methods and guidelines that are used to translate
HRQL questionnaires have in common and how do
they differ? and 2) is there empirical evidence pointing
to one or more methods as being superior to others?
Methods
We identiﬁed articles published between January 1966
and May 2005 relevant to translating HRQL question-
naires into other languages and adapting them to other
cultures. We ﬁrst performed a search of the MEDLINE
and Embase databases with the MeSH terms: “quality
of life,” “questionnaires,” and “health status indica-
tors” matched with “translating” and “cross-cultural
comparison.”
We considered articles without language restrictions
and excluded duplicates, and identiﬁed 468 references.
In addition, we performed a search of the database
of the Information Resources Center of Mapi Research
Trust using the search terms “translation issues,”
“cross-cultural comparison,” and “cross-cultural
research.” This provided us with another 423
references.
We chose to use this latter source of information,
because it was a repository of 13,400 articles, 180
books, periodicals, and unpublished reports on health
outcomes—compiled and regularly updated since
1995. The database is well indexed and is constantly
updated [20]. Most of the published material (articles
and book chapters), and unpublished documents have
been directly collected from the developers of PRO
questionnaires. The database is accessible at http://
www.mapi-research.fr/t_03_intr.htm/ Access is free for
researchers associated with academic institutions.
Two authors (C.A. and K.C.) reviewed the titles and
abstracts of the 891 references for relevance to the
study. The authors reviewed the articles together and
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compared their choices. All discrepancies were dis-
cussed and consensus was reached in all cases.
Articles were included if: 1) they proposed a set of
guidelines or recommendations; or 2) they reviewed,
compared or criticized methods to adapt HRQL ques-
tionnaires from a source culture to a target culture.
Results
Forty-ﬁve articles met our inclusion criteria. Twenty-
three articles representing 17 guidelines [14–17,21–39]:
• American Association of Orthopedic Surgeons
(AAOS) [21,22];
• The European Organisation for Research and
Treatment of Cancer (EORTC) Group [23];
• The European Quality of Life Instrument
(EUROQOL) Group [24];
• The European Group for Health Measurement
and Quality of Life Assessment (Nottingham
Health Proﬁle—NHP) [25,26];
• The Functional Assessment of Cancer Therapy
(FACT) Group [27];
• Flaherty et al. [15];
• Herdman et al. [16,17];
• The International Quality of Life Assessment
(IQOLA) Group [28,29];
• The Johns Hopkins University (Sickness Impact
Proﬁle—SIP) [30];
• Mapi Research Institute [31,32];
• Mathias et al. [33];
• The Medical Outcomes Trust (MOT) [34];
• Rahman et al. [35];
• Sperber [36];
• Spielberger and Sharma [37];
• Swaine-Verdier et al. [38];
• The World Health Organization (WHO) [14,39].
And 22 articles reviewing methods [12,13,18,
19,40–57].
Among these 45 articles, six discuss the language
issues fundamental to translating HRQL question-
naires [13,14,18,25,26,50], and seven explore the
key issue of “equivalence” in the international use of
HRQL questionnaires [14–19,43].
It is important to note that we found only three
studies that empirically compared different translation
methods: Falcao et al. [48], Maneesriwongul and
Dixon [53], and Perneger et al. [55].
One article written by the ISPOR Task Force for
translation and cultural adaptation proposes good
practices for the translation and the cultural adapta-
tion process for PROs [57]. Two other articles
comment and discuss the principles proposed by this
Task Force [51,54].
Review of Translation Methods Used or Recommended
Table 1 summarizes translation methods that were
either used and/or recommended in the articles
reviewed. It is beyond the scope of this article to
describe each of the 17 guidelines in detail. We chose to
focus on the following three guidelines because they
were not developed for a particular instrument, but a
wide range of questionnaires. In addition, they pre-
sented a novel feature, which distinguished them from
the others:
1. The guidelines proposed by Guillemin and Beaton
(i.e., the AAOS guidelines) were chosen because
they were the ﬁrst to propose an extensive review
of cross-cultural adaptation in 1993, and followed
up their research in 2000;
2. The Mapi Research Institute’s approach was
chosen because it was the ﬁrst to introduce a har-
monization step when using multiple language
versions of a given instrument in the same study.
3. Swaine and Verdier’s article was chosen because
the dual-panel approach they propose represents
an interesting contrast to the use of back-
translation, a step seen as essential by a majority
of groups and individuals working in the ﬁeld.
It should be noted that the ﬁrst two methods have
greatly beneﬁted from the pioneering work performed
by the EORTC Group [23] and the IQOLA Group
[28,29].
AAOS guidelines. Beaton and colleagues [21] propose
that cross-cultural adaptation is required for all self-
reported measures. They deﬁne cross-cultural adap-
tation as “a process that looks at both language
(translation) and cultural adaptation issues in the
process of preparing a questionnaire for use in another
setting.” They suggest in another article [22] that this
process should be “adapted” according to ﬁve different
situations, deﬁned by the target population (native,
established immigrants, new immigrants), the culture,
the language and the country of use. The options are
summarized in Table 2.
The guidelines described by Beaton and colleagues
are currently used by the AAOS Outcomes Committee.
The process for translation involves six stages, which
are described below.
Stage I: forward translation. They recommend that at
least two translations of the questionnaires be made
from the original language (source) to the target lan-
guage. Bilingual translators whose mother tongue is
the target language should produce the two inde-
pendent translations. Translator 1 (T1) should be
informed of the concepts being covered by the ques-
tionnaire, and should have a medical or clinical back-
ground. The idea is to produce a translation providing
equivalence from a measurement perspective. Transla-
tor 2 (T2) should be “naive,” less inﬂuenced by an
academic goal. The idea is to produce a translation
that reﬂects the language used by the layman. Each
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translator should produce a written report summariz-
ing all difﬁculties encountered, choices made or
remaining uncertainties.
Stage II: synthesis of the translations. Both translators,
T1 and T2, should work together with a recording
observer to produce one common consensus transla-
tion called T-12. Again, a written report should
document all issues addressed and how they were
resolved.
Stage III: back-translation. Two translators, totally
blind to the original version, translate the T-12 version
back into the original language. The objective is to
check that the translated version reﬂects the same item
content as the original. Two back-translations are con-
sidered as a minimum, and should be produced by two
“naive” individuals whose mother tongue is the source
language. Each translator should produce a written
report.
Stage IV: expert committee. This committee should be
composed of methodologists, health professionals, lan-
guage professionals, and all the translators involved in
the process. The original developers of the question-
naire should be in close contact with this committee.
Its role is to develop the preﬁnal version for ﬁeld-
testing. The committee should review all the transla-
tions, and reach consensus on any discrepancy. The
goal is to achieve four types of equivalence: semantic
(i.e., equivalence in meaning of words), idiomatic (i.e.,
equivalent expressions have to be found or items have
to be substituted), experiential (i.e., the situation
evoked or depicted in the source version should ﬁt the
target cultural context) and conceptual (i.e., is the
concept explored valid in the target culture?). Again all
decisions should be documented.
Stage V: test of the preﬁnal version. Ideally, 30 to 40
persons should be tested. Each subject should complete
the questionnaire and be interviewed about the
meaning of each item. Distribution of responses should
be examined to check the proportion of missing items.
This stage provides a rough evaluation of content
validity.
Stage VI: submission of documentation to the devel-
opers or coordinating committee for appraisal of the
adaptation process. This is a process to ensure that all
steps have been performed and fully documented.
Mapi Research Institute’s methodology. Since 1995,
Mapi Research Institute [31,32] has proposed methods
similar to those described by Beaton et al. and has
labeled the process Linguistic Validation. The Institute
has, however, added a step: the International Harmo-
nization. It takes place after the test of the preﬁnal
version, whenever the original questionnaire is trans-
lated into several languages simultaneously. The aim
is to perform further quality control and to ensure
greater comparability between source and target ver-
sions. In contrast to the other steps of the linguistic
validation, this takes place in one country and in the
presence of professional translators representing each
target language. The harmonization is achieved at a
meeting between translators, the coordinating center
and the author. It follows a speciﬁc pattern:
1. A reminder of the concepts intended to be repre-
sented by each item.
2. The analysis of the translation decisions made in
each language group of the same origin (Latin,
Scandinavian, Asian, etc.) and a review of certain
choices to reconcile them with those of the same
group.
3. The submission of the proposed changes to the
local team for approval and production of the
ﬁnal target version; and the production of a report
explaining the methodology followed and the
translation choices made.
Great care is taken at this stage not to smooth over
each language’s distinctiveness but to respect their con-
ceptual, semantic, and cultural differences, which lead
to the production of appropriate, target versions. In
contrast to other methodologies [27,33], the Institute’s
approach stresses the importance of performing trans-
lation work in the target countries as translations
made in the source country have often been inadequate
either because of gross errors of syntax or mistakes at
the conceptual level.
Table 2 Cross-cultural adaptation of HRQL questionnaires in ﬁve different settings [21]
Target population Culture Language Country Recommended process
Same population Same Same Same None
Established immigrants in the same country Different Same Same Cultural adaptation
Another country, but with the same language Different Same Different Cultural adaptation
(e.g., questionnaire developed in France to
be adapted in Canadian French)
New immigrants, not speaking the source
language, living in the same source country
Different Different Same Translation and cultural adaptation
Different population Different Different Different Translation and cultural adaptation
HRQL, Health-Related Quality of Life.
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The Institute speciﬁes that in a classical linguistic
validation process no less than 15 people are involved
for each language, each having a precise role in the
production of an appropriate target version. Organi-
zation of these steps by a coordinating center, together
with close collaboration with the author of the
questionnaire, ensures greater coherence of the ﬁnal
versions. The Institute also emphasizes the importance
of documenting each step in detail to facilitate access
to translation issues and their solutions at a later stage.
Dual translation panels (Swaine-Verdier et al.).
Swaine-Verdier and colleagues [38] argue that the
forward/backward translation method is controver-
sial, and describe an alternative method involving dual
translation panels used in the production of all adap-
tations of needs-based quality of life (QoL) instru-
ments. The needs-based model of QoL postulates that
life gains its quality from the ability of the individual to
satisfy his or her needs. QoL is high when these needs
are fulﬁlled and low when few needs are satisﬁed
[58,59].
Swaine-Verdier et al. base their arguments on the
assumption that it is better to produce quality in
the translation, rather than checking it through
back-translation.
They make the following recommendations:
• Recruit translators (ﬁve to seven) with varied pro-
ﬁles to work as a team in a group meeting.
• Inform the group of the concepts underlying
the questionnaire, its development, design, and
content.
• Inform them of the translations requirements (i.e.,
conceptual equivalence, accessibility and accept-
ability of wording).
• Have them work under the supervision of an
experienced coordinator.
• Have the agreed translation assessed by a lay
panel working as a focus group.
• The whole procedure should be reported in detail.
The authors emphasize that translation is only the
start of the adaptation process. Further steps include:
1. Pilot testing by means of face-to-face interviews
with several (15–20) representatives of the target
population, to ensure linguistic, face, and content
validity.
2. The evaluation of the psychometric properties of
the adapted questionnaire.
3. The assessment of differential item functioning
(DIF) between the source and the target version;
the absence of DIF indicating measurement
equivalence.
The basis of this theory lies in the item response
function, the S-shaped trace of the proportion of indi-
viduals at the same ability level who answer a given item
correctly. Under the assumption that the ability under
consideration is unidimensional and that the item mea-
sures the same ability, the trace is unique under the
conditions of a particular model. Except for random
variations the same curve is found, irrespective of the
nature of the group for whom a function is plotted.
Items that do not yield the same item response function
for two or more groups are violating one of the funda-
mental assumptions of Item Response Theory, that the
item and the test in which the item is contained are
measuring the same unidimensional trait [60].
Review of Articles Comparing or Discussing Methods
Perneger et al. [55] compared the IQOLA group’s
methodology (see Table 1) and a less rigorous method
in which neither a back-translation nor an expert
review was done. In Perneger’s “Geneva” method,
translators who knew nothing about the IQOLA
French version of the SF-36 translated the original
SF-36 into French.
The Geneva method is brieﬂy described below:
1 Recruited three translators from the medical/
health ﬁeld, each having a different specialty.
2 Produced three independent forward translations.
3 Synthesized the three translations into a single
version by a panel of experts from various ﬁelds of
language and health survey.
4 Tested the “ﬁnal” version for acceptability on two
sample groups (n = 15 and 35) belonging to the
target population.
The authors then compared the psychometric prop-
erties of the “ofﬁcial” IQOLA translation to those of
their “Geneva” version administered to the same
group of respondents. The investigators concluded
that, in this particular case, the more complex IQOLA
translation procedure did not pay off in measurably
better psychometric performance.
Falcao et al. [48] drew similar conclusions, question-
ing the complexity of the methodologies proposed in
the translation of questionnaires. Two versions of the
Health Assessment Questionnaire (HAQ), the SF-36
and the Arthritis Impact Measurement Scale (AIMS-2)
were administered to a sample of 50 patients with
rheumatoid arthritis. Version 1 was a literal translation
of the questionnaire. Version 2 resulted from a process
of cultural adaptation following internationally ac-
cepted guidelines as recommended by Beaton et al. [21]
and Guillemin et al. [22]. Questionnaires were admin-
istered before and after a medical consultation. The
questionnaire, the order of administration and the
version were randomly assigned. Versions 1 and 2
yielded a similar clinically and statistically signiﬁcant
correlation with clinical and laboratory measures in the
validation process of the questionnaires. Hence, Falcao
et al. proposed the simpliﬁcation of the AAOS method-
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ology by maintaining the basic process (i.e., forward/
backward translations, review by expert committee,
pretest), but reducing the complexity of each step.
Perneger and Falcao do not question the need for
rigorous methods and the importance of a multistep
approach in the translations of HRQL measures, but
they discuss the complexity of some procedures,
arguing that lighter approaches are acceptable.
In another article, Leplège [52] questioned the value
of the back-translation method proposed by Brislin
[44]. Providing examples that back-translations are at
least as misleading as they are informative, he con-
cluded that back-translation is “not the infallible
quality control tool it is purported to be.” Therefore,
assuming that the priority is to obtain high-quality
forward translations, Leplège provides suggestions
about the translators’ recruitment criteria and training
(e.g., linguistically competent, fully briefed, should
have prior experience in the ﬁeld and should be able to
comment on their own translation). Along the same
lines, Swaine-Verdier et al. [38] advise against back-
translation and proposed the use of dual translation
panels. Nevertheless, we could not locate any study
that compared these methods (back-translation vs.
dual-panel translation). Finally, other authors [11,31],
aware of the pitfalls of the back-translation, suggest
that the back-translator should produce a version as
literal as possible.
In a recent article [53], Maneesriwongul and Dixon
reviewed different processes of instrument translation
and evaluation of translation adequacy in the published
nursing research. They examined 47 studies, which they
classiﬁed into six categories. For studies with forward
translations only, they created two categories to distin-
guish between those with no test of the translation from
those with a test. For studies with forward and back-
translation, four categories were created to distinguish
between those with no test, monolingual test, bilingual
test or both kinds of test. They clearly indicated a
hierarchy in quality, with category 1 (forward-only
translation) indicating a minimal level of effort and a
lower quality of translations, and category 6 (back-
translation with monolingual and bilingual tests) dem-
onstrating a substantial effort to ensure the validity of
the translation. In the light of their ﬁndings, they
advised that multiple techniques should be used in all
cross-cultural research, and regretted the lack of con-
sensus among researchers on how these techniques
should be used or combined. They recommended that
minimum standards for applying an instrument devel-
oped in another language should include back-
translation and testing among target language subjects
to allow detection and correction and discrepancies of
translation, as well as evaluation of clarity and appro-
priateness with future subjects. Finally, they called for
more detailed information about translation processes
in reports and articles.
Discussion
Issues of Deﬁnition
During our literature review we encountered a lack of
consensus among authors on critical terms used in the
articles. We found, for example, different descriptions
of the process of “translating” or “culturally adapt-
ing” a HRQL questionnaire.
Although the IQOLA project guidelines [28,29]
deﬁne “translation methods” to include the produc-
tion of forward and backward translations, use of
difﬁculty and quality ratings, pilot testing, and cross-
cultural comparison of the translation work, the guide-
lines for the translation of a generic questionnaire (the
SIP) [30] have proposed that translating HRQL instru-
ments into other languages implies the translation
itself, the evaluation of the psychometric properties
and weighing of the translation, and ﬁeld-testing
(responsiveness, norms, etc.).
The difference in meaning between the terms “cul-
tural” and “cross-cultural,” as used in cultural/cross-
cultural adaptation was also not clear. According to
one author [21], the “cultural adaptation” step follows
the translation step and these two steps together form
the process of “cross-cultural adaptation.” Other
authors seem to use these terms synonymously. In early
publications (1993) Guillemin et al. [22] state that
“cross-cultural adaptation has two components: the
translation of HRQL measure and its adaptation, i.e.,
a combination of the literal translation of individual
words and sentences from one language to another and
an adaptation with regards to idiom, and to cultural
context and lifestyle.” More recent publications
[31,32] state that “cultural adaptation” needs to be
performed in two steps: translation (linguistic valida-
tion) and evaluation of the psychometric properties
(psychometric validation) of the HRQL questionnaire.
The translation of HRQL instruments for use in
another culture is still a science under development.
Because the terminology of a developing science has not
had sufﬁcient time to mature, investigators need to
deﬁne clearly and precisely the terms they use.Herdman
et al. [16] emphasize this need when they point out that
there are at least 19 different types of “equivalence”
mentioned in the literature and “conceptual equiva-
lence” is used in at least 19 different ways.
We would recommend that the scientiﬁc community
produce a consensus glossary, which would be made
available to nonexperts in the ﬁeld (e.g., regulators,
clinicians, etc.). As part of its objectives, the Cochrane
Patient-Reported Outcomes Methods Group is cur-
rently undertaking such a task [61].
Comparison of Translation Methods
All the articles discuss the subjectivity of translating
HRQL questionnaires and provide substantial infor-
mation about the requirements, qualiﬁcations or char-
Review of Methods to Translate HRQL Measures 517
acteristics of the people involved in the process.
Among the guidelines listed in Table 1 some common
features were: a multistep and centralized review
process, at least one forward translation and some
form of pretesting. Other than that, the methods vary
considerably. Some groups recruit professionally edu-
cated people in their procedure and others recruit
people of the same educational level as that of the
target population; some groups have the translators
work independently and others have them work as a
team; some groups include a back-translation step in
their procedure and other groups do not; some groups
consolidate several forward translations into one
version for back-translation and others back-translate
each of the forward translations separately; some con-
solidate the translations using the same translators and
others use independent people to do the consolidation.
The pretesting step also varies considerably between
groups. Some groups involve patients in a focus group;
others use monolingual or bilingual panels and some
include a cognitive debrieﬁng step in their method.
Finally, some groups recommend the international
harmonization step when several translations are
performed concomitantly. These differences reﬂect
theoretical differences between groups in deﬁnitions of
equivalence [14–19], approaches to development
[12,40,41,47,56], as well as the trade-offs made (e.g.,
available resources [33,42,49]).
Beaton [21] and Guillemin [22] highlight the im-
portance of thoroughly documenting each step of the
process. Criteria for recruiting translators are provided
in detail. There is no indication, however, as to whether
the forward translators should be residents of the target
country. The categorization of the target population
(i.e., native, established or new immigrants) is very sen-
sible. In line with other authors [19], it underscores the
need to take the immigration status into consideration.
Although there is some evidence that different
methods (i.e., “light/simpler” vs. “heavy/complex”)
yield similar results [48,55], this has been tested
empirically only on a very limited scale, and needs
further research to be widely acceptable. Other
ﬁndings suggest that a one-step approach (i.e., one
forward only or a committee approach only) casts a
shadow on the validity of the ﬁnal outcome [53].
Producing only one forward translation involves a
total dependence on the translator’s skill and knowl-
edge, and often results in low validity and reliability.
Using the committee approach, serious limitations arise
if committee members have common views or if pres-
sure is felt to form a consensus. Finally, we found
evidence that most rigorous and centralized procedures
provide the best outcomes in terms of equivalence [53].
Our ﬁndings are similar to those published by the
ISPOR Task Force for translation and cultural adap-
tation, although the methods under review do not
overlap [57]. In addition, we agree with McKenna [54]
and Lenderking [51] when they argue that evidence
should be collected before asserting that any speciﬁc
method represents principles of good practice.
Although, as a result of the lack of scientiﬁc evi-
dence in favor of one speciﬁc method of translation we
could not identify a “best bet” method, we strongly
advise researchers to adopt a multistep approach to
ensure quality [53]. This advice is in line with the
current recommendation of the recent FDA draft guid-
ance, to consider generally accepted methods for trans-
lations and cultural adaptations [10]. Nevertheless, we
argue that the main subject of controversy with the
draft guidance lies in the last sentence of the recom-
mendation: “Sponsors should consider whether gener-
ally accepted standards for translation and cultural
adaptation have been used to support the validity of
data from a translated/adapted PRO instrument,
including but not restricted to the following: [. . .] The
evidence that measurement properties for translated
versions are comparable.”
Although reaching measurement equivalence would
be ideal, we would argue that there is a need to adopt
a more pragmatic approach in the context of clinical
trials that emphasizes the need for conceptual equiva-
lence, and allows evidence of measurement equiva-
lence to emerge over time. Cognitive debrieﬁng in the
target countries is one of the means to ensure that
conceptual equivalence between the source and the
target versions is retained, and represents a way of
“bridging” between languages and cultures. Another
option would be to add to a well-conducted cultural
adaptation process a test of between-country hetero-
geneity as a prerequisite for pooling trial data. This
could form the basis for the proper interpretation of
international trial results.
Conclusions
Several points emerge from this review. First, producing
high-quality translation is labor-intensive and time-
consuming. Second, the availability of standardized
guidelines and centralized review procedures can
improve the quality of the translations and the efﬁciency
with which those translations are produced. There is
some evidence that a rigorous and amultistep processed
method with centralized review procedures leads to
better translations. In addition, the people involved in
the translation process are critical in determining a
questionnaire’s performance in a new country or
culture. Consequently, to ensure credibility of their
methods, investigators need to speciﬁcally describe the
process used and justify their recruitment criteria.
Although we did not ﬁnd evidence in favor of one
speciﬁc method of translation, we strongly advise
researchers to adopt a multistep approach as a guar-
antee of quality. Toward this end, and in line with the
FDA recommendations, we have developed a checklist,
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which summarizes the major steps commonly included
for the translation of HRQL questionnaires for inter-
national use, and can be used to evaluate the rigor of
the translation methodology employed.
The major focus of this checklist is on whether the
translation process is based on a multistep approach,
and whether each step is thoroughly documented. We
believe that documentation of each step is crucial in
that it allows tracking of all the decisions made during
the process.
Item 1 requests information about potential con-
tacts with the developer(s) of the HRQL questionnaire
to be translated. Was (were) developer(s) aware of and
involved in the translation process?
Items 2 to 4 deal with the forward-translation
process. The checklist explores the availability of
detailed information about the translators involved in
the process, the number of forward translations pro-
duced and the steps taken to produce a reconciled
forward version.
In the absence of a back-translation step (i.e., use of
the dual-panel method), Item 5 deals with the approval
of the reconciled forward translation as the Target
Version for pilot testing.
Items 6 to 8 deal with the back-translation process.
The checklist explores the availability of detailed infor-
mation about the translators involved in the process,
the number of back-translations produced, the analysis
of the back-translation(s), and how the reconciled
forward translation was revised according to the
review of the back-translation(s).
In the absence of a back-translation step, Item 9
deals with the approval of the reconciled forward
translation as the Target Version for pilot testing.
Item 10 deals with the description of the pilot
testing of the target version to verify that respondents
from the target population clearly understand, accept
and can easily respond to the target language version.
Item 11 is concerned with the use of International
Harmonization.
To provide insight into the types of equivalence
covered by this checklist, we have linked each step to
its corresponding level of equivalence as described by
Stewart and Napoles [19]. Based on the deﬁnitions of
equivalence and the methods to achieve them provided
by the authors, Items 1 and 11 of the checklist cover
conceptual equivalence, Items 2 to 12 apply to seman-
tic equivalence, and Item 11 is also relevant to opera-
tional equivalence. This checklist only explores three
types of equivalence, and does not include the other
three types of equivalence described by Stewart and
Napoles [19] (i.e., psychometric, item, and criterion)
where more empirical research is needed.
Source of ﬁnancial support: the European Regulatory Issues
on Quality of Life Assessment (ERIQA) Group (http://
www.eriqa-project.com).
Supplementary materials for this article can be found at:
http://www.ispor.org/publications/value/ViHsupplementary.
asp
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